Avastin (bevacizumab) - Angiogenesis Inhibitor and Cancer Therapy

Print-Icon
Print

To meet the growing demand for licensed products and new drugs coming on stream, Genentech is increasing production capacity.
 
«Back




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development